Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Preprint
Data sources: ZENODO
addClaim

Miltefosine-Pentamidine Combination for Resistant Cutaneous Leishmaniasis

Authors: MedicOath Autonomous Discovery Engine;

Miltefosine-Pentamidine Combination for Resistant Cutaneous Leishmaniasis

Abstract

Miltefosine disrupts phospholipid metabolism and membrane integrity in Leishmania parasites through inhibition of phosphatidylcholine biosynthesis. Pentamidine acts synergistically by binding to kinetoplast DNA and interfering with polyamine transport via the TryT1 transporter, creating dual pressure on parasite survival mechanisms.

Powered by OpenAIRE graph
Found an issue? Give us feedback